Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Janus kinase versus TNF inhibitors: where we stand today in rheumatoid arthritis
Aliki I. Venetsanopoulou, Paraskevi V. Voulgari, Alexandros A. Drosos
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 5, pp. 485-493
Closed Access | Times Cited: 17

Showing 17 citing articles:

Exploring the therapeutic potential of regulatory T cell in rheumatoid arthritis: Insights into subsets, markers, and signaling pathways
Q. Y. Su, Huan-Cheng Li, Xiaojing Jiang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116440-116440
Open Access | Times Cited: 7
Recurrent Scedosporium apiospermum Cutaneous Infection in a Patient with Rheumatoid Arthritis: The Potent Role of IL-6 Signaling Pathway Blockade: A Case-Based Review
Antigone Pieta, Aliki I. Venetsanopoulou, Christos Kittas, et al.
Journal of Fungi (2023) Vol. 9, Iss. 6, pp. 683-683
Open Access | Times Cited: 9
PERFECTRA: a pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs
Celine Johanna van de Laar, Martijn A. H. Oude Voshaar, Peter M. ten Klooster, et al.
RMD Open (2024) Vol. 10, Iss. 2, pp. e004291-e004291
Open Access | Times Cited: 3
Anti-inflammatory and anti-rheumatic effects of Phoenix dactylifera L. (date palm) seed by controlling cytokines and inhibiting JAK1/STAT3 pathway on CFA-induced arthritis rat and its phytochemical profiling
Zeinab A. El-Gendy, Shimaa Abdelazeem, Gehad A. Abdel Jaleel, et al.
Journal of Ethnopharmacology (2024) Vol. 329, pp. 118138-118138
Closed Access | Times Cited: 2
Investigational bispecific antibodies for the treatment of rheumatoid arthritis
Aliki I. Venetsanopoulou, Paraskevi V. Voulgari, Alexandros A. Drosos
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 7, pp. 661-670
Closed Access | Times Cited: 2
Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study
Andrea Rubbert‐Roth, Koji Kato, Boulos Haraoui, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 5, pp. 1197-1215
Open Access | Times Cited: 2
Cost-effectiveness of janus kinase inhibitors for rheumatoid arthritis: A systematic review and meta-analysis of cost-utility studies
S. Sajith Kumar, Madhumitha Haridoss, Krishnamurthy Venkataraman, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
A Real-World Effectiveness Study Using a Mobile Application to Evaluate Early Outcomes with Upadacitinib in Rheumatoid Arthritis
Leslie R. Harrold, Patrick Zueger, W. Benjamin Nowell, et al.
Rheumatology and Therapy (2023) Vol. 10, Iss. 6, pp. 1519-1533
Open Access | Times Cited: 4
Efficacy and safety of different Janus kinase inhibitors combined with methotrexate for the treatment of rheumatoid arthritis: a single-center randomized trial
Liao Xiao-ling, Huo Wang, Wen Zeng, et al.
Advances in Rheumatology (2023) Vol. 63, Iss. 1
Open Access | Times Cited: 4
Development of Morphea Following Treatment with an ADA Biosimilar: A Case Report
Aliki I. Venetsanopoulou, Konstantina Mavridou, Eleftherios Pelechas, et al.
Current Rheumatology Reviews (2024) Vol. 20, Iss. 4, pp. 451-454
Closed Access | Times Cited: 1
Optimizing withdrawal strategies for anti-TNF-α therapies in rheumatoid arthritis
Aliki I. Venetsanopoulou, Paraskevi V. Voulgari, Alexandros A. Drosos
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 8, pp. 815-825
Closed Access | Times Cited: 1
Sphingosine 1-phosphate receptor modulators for the treatment of inflammatory bowel disease and other immune-mediated diseases
Lifan Xu, Peng Lu, Yubin Wang
Medicinal Chemistry Research (2022) Vol. 31, Iss. 12, pp. 2074-2088
Closed Access | Times Cited: 5
miRNA-Mediated Epigenetic Regulation of Treatment Response in RA Patients—A Systematic Review
Arkaitz Mucientes, José Manuel Lisbona-Montañez, Natalia Mena‐Vázquez, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12989-12989
Open Access | Times Cited: 5
Biological properties and diverse cytokine profiles followed by in vitro and in vivo infections with LSDV strain isolated in first outbreaks in Vietnam
Tuan-Anh Tran, Anh Duc Truong, Dung T.K. Nguyen, et al.
Veterinary Research Communications (2023) Vol. 47, Iss. 4, pp. 2005-2016
Closed Access | Times Cited: 1
Long-Term Safety and Efficacy of Janus kinase (JAK) Inhibitors in the Treatment of Rheumatoid Arthritis
Shumaila , Furqan Yousuf, Amtul Muizz Noor, et al.
Developmental medico-life-sciences (2024) Vol. 1, Iss. 4, pp. 71-78
Closed Access
Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status
Alexis Ogdie, Lars Erik Kristensen, Enrique R. Soriano, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 6, pp. 1649-1664
Open Access
Rheumatoid Arthritis
Eleftherios Pelechas, Evripidis Kaltsonoudis, Paraskevi V. Voulgari, et al.
Springer eBooks (2023), pp. 113-147
Closed Access
Page 1

Scroll to top